cystic-fibrosis

Documents about cystic-fibrosis

• Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del#329545ClinicalTrials.gov
• Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study)#803642ClinicalTrials.gov
• Hyperpolarized Xenon MRI in Cystic Fibrosis Pulmonary Exacerbations#804364ClinicalTrials.gov
• Efficacy of Simeox Airway Clearance Therapy in Children With Cystic Fibrosis#808113ClinicalTrials.gov
• Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients#833056ClinicalTrials.gov
• Should Any One Airway Clearance Technique be Recommended for People With Cystic Fibrosis?#834485ClinicalTrials.gov
• SynRinse Irrigation Pilot (SIP) Trial#841367ClinicalTrials.gov
• e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population#848228ClinicalTrials.gov
• Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)#852096ClinicalTrials.gov
• Rare Genetic Disorders of the Breathing Airways#853559ClinicalTrials.gov
• Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000#865090ClinicalTrials.gov
• A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis#881038ClinicalTrials.gov
• Exercise and Oscillatory Positive Expiratory Pressure Therapy in Cystic Fibrosis#891316ClinicalTrials.gov
• PACE CF, a 3-session Mind-body Pain Management Program for Adults With Cystic Fibrosis#891572ClinicalTrials.gov
• Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients#913464ClinicalTrials.gov
• Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung#979050ClinicalTrials.gov
• Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation#1008988ClinicalTrials.gov
• Pilot Study of Behavioural Intervention for Nutrition in Cystic Fibrosis#1010683ClinicalTrials.gov
• Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)#417506ClinicalTrials.gov
• Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.#444894ClinicalTrials.gov
• Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse Sequences#804778ClinicalTrials.gov
• Inhaled Therapy Adherence and Outcomes to Kaftrio in Cystic Fibrosis#840900ClinicalTrials.gov
• Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis#845449ClinicalTrials.gov
• Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic Fibrosis#845653ClinicalTrials.gov
• Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group#856852ClinicalTrials.gov
• Effects Of Noninvasive Ventilation On Functional Capacity Of Patients With Cystic Fibrosis#866890ClinicalTrials.gov
• Preventing Depression and Anxiety: A Cystic Fibrosis-Specific Cognitive Behavioral Therapy Intervention#879629ClinicalTrials.gov
• A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease#883052ClinicalTrials.gov
• A Study of RPL554 in Patients With Cystic Fibrosis#893782ClinicalTrials.gov
• Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)#895918ClinicalTrials.gov
• Maralixibat in Patients With Cystic Fibrosis and Constipation#897296ClinicalTrials.gov
• Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease#913998ClinicalTrials.gov
• A Study Evaluating the Efficacy and Safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects, Homozygous for F508del#979767ClinicalTrials.gov
• Evaluation of the ReX-C System, in Patients Receiving CFTR Modulators for the Treatment of Cystic Fibrosis (CF).#1008496ClinicalTrials.gov
• A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis#811301ClinicalTrials.gov
• Effects of Vitamin D Supplementation on Lung Function in an Acute Pulmonary Exacerbation of Cystic Fibrosis#826757ClinicalTrials.gov
• Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT)#828226ClinicalTrials.gov
• Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT#843991ClinicalTrials.gov
• Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis#850820ClinicalTrials.gov
• Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea#866551ClinicalTrials.gov
• Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With Cystic Fibrosis (CF)#870612ClinicalTrials.gov
• Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment#876478ClinicalTrials.gov
• A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TOPIC)#876573ClinicalTrials.gov
• Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis#880690ClinicalTrials.gov
• Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older#885869ClinicalTrials.gov
• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of VX-661/Ivacaftor in Pediatric Subjects With Cystic Fibrosis (CF)#887653ClinicalTrials.gov
• Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)#907744ClinicalTrials.gov
• Study of Peripherally Inserted Venous Catheters in Cystic Fibrosis Patients#917166ClinicalTrials.gov
• Heart and Blood Vessels Health in People With Cystic Fibrosis#801102ClinicalTrials.gov
• Progressive Muscle Relaxation in Pulmonary Rehab for Quality of Life, Mental Health, and Sleep in Cystic Fibrosis#895594ClinicalTrials.gov